Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues
1996

c-kit Expression in Breast Tissues

Sample size: 135 publication Evidence: moderate

Author Information

Author(s): X Chui, H Egami, J Yamashita, T Kurizaki, H Ohmachi, S Yamamoto, M Ogawa

Primary Institution: Kumamoto University Medical School

Hypothesis

The study investigates the relationship between c-kit proto-oncogene product expression and malignant transformation in breast tissues.

Conclusion

The loss of c-kit proto-oncogene product expression may indicate changes in signal transduction related to malignant transformation in breast tissue.

Supporting Evidence

  • The average immunoreactive score (IRS) of normal breast tissue was 6.22 ± 2.11.
  • In benign breast diseases, the average IRS was 3.33 ± 2.44.
  • In breast cancer tissues, the average IRS was significantly lower at 0.43 ± 1.27.
  • Complete deletion of c-kit expression was found in 70.2% of breast cancer tissues.

Takeaway

This study looked at how a specific protein, c-kit, behaves in normal and cancerous breast tissues. It found that normal tissues have a lot of this protein, but cancerous tissues often have much less.

Methodology

The study used immunohistochemistry to analyze c-kit expression in breast tissues from patients with cancer, benign diseases, and normal tissues.

Limitations

The study did not find significant relationships between c-kit expression and various clinicopathological parameters.

Participant Demographics

All participants were female, with ages ranging from 22 to 89 years.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication